Colon cancer blood test offers new screening option
A blood test for colon cancer performed well in a study published Wednesday, offering a new kind of screening for a leading cause of cancer deaths.
The test looks for DNA fragments shed by tumor cells and precancerous growths. It’s already for sale in the U.S. for $895, but has not been approved by the Food and Drug Administration and most insurers do not cover it. The maker of the test, Guardant Health, anticipates an FDA decision this year.
In the study, the test caught 83% of the cancers but very few of the precancerous growths found by colonoscopy, the gold standard for colon cancer screening. Besides spotting tumors, colonoscopies can prevent the disease by removing precancerous growths called polyps.
But some people avoid the exam because of the hassle of getting time off work or the day-ahead preparation that involves drinking a strong laxative to empty the bowels.
Related articles
Pogacar extends Giro lead to over 7 minutes after winning altered Stage 16 amid protests at start
SANTA CRISTINA, Italy (AP) — After a chaotic, wet and unusual start to the 16th stage of the Giro d’2024-05-22Bill disestablishing Māori Health Authority to go through Parliament under urgency today
Photo: RNZ / Angus Dreaver2024-05-22Rare PINK elephant is captured playing in a South African waterhole
A safari operator in South Africa has captured footage of a rare young pink elephant hopping and pla2024-05-22REVEALED: The worst airports in the US
Dirty bathrooms, a lack of comfortable seating and confusing terminal maps - these are just a few of2024-05-22- NASHVILLE, Tenn. (AP) — A 10-year-old Tennessee boy who was swept into a storm drain after severe we2024-05-22
More toll roads coming, but at what price?
Photo: NZTA2024-05-22
atest comment